Amorphous solid dispersions: Rational selection of a manufacturing process

T Vasconcelos, S Marques, J das Neves… - Advanced drug delivery …, 2016 - Elsevier
Amorphous products and particularly amorphous solid dispersions are currently one of the
most exciting areas in the pharmaceutical field. This approach presents huge potential and …

Enhancing solubility of poorly aqueous soluble drugs: Critical appraisal of techniques

D Singh, N Bedi, AK Tiwary - Journal of pharmaceutical investigation, 2018 - Springer
A wide variety of new medication disclosures launched by specific benefits of the general
public are laced with poor aqueous solubility problems that often obstruct their bioavailability …

Cilostazol-loaded poly (ε-Caprolactone) electrospun drug delivery system for cardiovascular applications

M Rychter, A Baranowska-Korczyc, B Milanowski… - Pharmaceutical …, 2018 - Springer
Purpose The study discusses the value of electrospun cilostazol-loaded (CIL) polymer
structures for potential vascular implant applications. Methods Biodegradable …

Enhanced biopharmaceutical performance of rivaroxaban through polymeric amorphous solid dispersion

S Metre, S Mukesh, SK Samal, M Chand… - Molecular …, 2018 - ACS Publications
Rivaroxaban (RXB) is an orally active direct inhibitor of the activated serine protease Factor
Xa, given as monotherapy in the treatment of venous thromboembolism (VTE). It has been …

An investigation into solubility and dissolution improvement of alectinib hydrochloride as a third-generation amorphous solid dispersion

SK Saha, A Joshi, R Singh, S Jana, K Dubey - Journal of Drug Delivery …, 2023 - Elsevier
Poorly water-soluble drugs belonging to BCS Class II and IV present a big challenge to
formulators owing to their limited solubility and bioavailability. Alectinib hydrochloride (ALB) …

Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions

PW Dhore, VS Dave, SD Saoji, YS Bobde… - Pharmaceutical …, 2017 - Taylor & Francis
In the present study, a lyophilized milk-based solid dispersion (SD) of ritonavir (RTV) was
developed with the goal of improving its aqueous solubility. The SD was prepared by …

[HTML][HTML] Nanosuspension with improved saturated solubility and dissolution rate of cilostazol and effect of solidification on stability

I Aghrbi, V Fülöp, G Jakab, N Kállai-Szabó… - Journal of Drug Delivery …, 2021 - Elsevier
The aim of the study was to formulate cilostazol containing nanosuspension by top-down
wet milling method in order to increase the in vitro solubility and dissolution rate of this …

Long-lasting anti-platelet activity of cilostazol from poly (ε-caprolactone)-poly (ethylene glycol) blend nanocapsules

MLS Gomes, N da Silva Nascimento… - Materials Science and …, 2019 - Elsevier
Cilostazol (CLZ) acts as a vasodilator and antiplatelet agent and is the main drug for the
treatment of intermittent claudication (IC) related to peripheral arterial disease (PAD). The …

Enteric Polymer–Based Amorphous Solid Dispersions Enhance Oral Absorption of the Weakly Basic Drug Nintedanib via Stabilization of Supersaturation

Y Qin, C Xiao, X Li, J Huang, L Si, M Sun - Pharmaceutics, 2022 - mdpi.com
The pH–induced crystallization of weakly basic drugs in the small intestine limits oral
bioavailability. In this study, we investigated the solubilization and inhibitory effects on …

Electrospun poly (lactic acid)(PLA)/poly (butylene adipate-co-terephthalate)(PBAT) nanofibers for the controlled release of cilostazol

LR Antunes, GL Breitenbach, MCG Pellá… - International Journal of …, 2021 - Elsevier
Drug delivery devices are attractive alternatives to drugs usually orally administrated.
Therefore, this work aimed to produce PLA/PBAT-based nanofibers for the controlled …